-
241por Breitkopf, Carmen Radecki, Sinicrope, Pamela S, Rabe, Kari G, Brockman, Tabetha A, Patten, Christi A, McWilliams, Robert R, Ehlers, Shawna, Petersen, Gloria M“…BACKGROUND: Pancreatic cancer (PC) is considered the most lethal cancer and approximately 10% of PC is hereditary. …”
Publicado 2012
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
242“…Recently, three transcription factors—nuclear factor-κB (NF-κB), nuclear factor of activated T cells (NFAT) and nuclear factor-E2-related factor-2 (Nrf2)—have been shown to be crucial for tumor development and chemoresistance in pancreatic cancer. These transcription factors are key regulators of a variety of genes involved in nearly all aspects of tumorigenesis and resistance against chemotherapeutics and death receptor ligands. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
243
-
244por Suzuki, Shuji, Furukawa, Toru, Oshima, Nana, Izumo, Wataru, Shimizu, Kyoko, Yamamoto, Masakazu“…BACKGROUND: This retrospective study aimed to evaluate clinicopathological findings of remnant pancreatic cancers in survivors of invasive ductal adenocarcinomas of the pancreas (PDAC). …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
245
-
246por Nalls, Dara, Tang, Su-Ni, Rodova, Marianna, Srivastava, Rakesh K., Shankar, Sharmila“…BACKGROUND: MicroRNA-34a (miR-34a) is a transcriptional target of p53 and is down-regulated in pancreatic cancer. This study aimed to investigate the functional significance of miR-34a in pancreatic cancer progression through its epigenetic restoration with chromatin modulators, demethylating agent 5-Aza-2′-deoxycytidine (5-Aza-dC) and HDAC inhibitor Vorinostat (SAHA). …”
Publicado 2011
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
247por Gao, Song, Pan, Yan, Song, Libin, Dong, Lei, Weng, Lao I., Wang, Peng, Hua, Yongqiang, Chen, Zhen, Liu, Luming“…However, there is little published information regarding the underlying clinical significance and mechanisms of transcription factor Nanog in pancreatic cancer. In this study, our results indicated that Nanog is overexpressed in human pancreatic cancer stem cells and downregulated by QYHJ, which may contribute to explain the clinical effectiveness of QYHJ and provide advanced pancreatic cancer patients with a new therapeutic option, supporting our hypothesis that the degradation pathway is another mechanism by which QYHJ affects Nanog expression.…”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
248por Tanouchi, Aki, Taniuchi, Keisuke, Furihata, Mutsuo, Naganuma, Seiji, Dabanaka, Ken, Kimura, Masashi, Watanabe, Ryohei, Kohsaki, Takuhiro, Shimizu, Takahiro, Saito, Motoaki, Hanazaki, Kazuhiro, Saibara, ToshijiEnlace del recurso
Publicado 2016
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
249por Sikander, Mohammed, Malik, Shabnam, Khan, Sheema, Kumari, Sonam, Chauhan, Neeraj, Khan, Parvez, Halaweish, Fathi T., Chauhan, Bhavin, Yallapu, Murali M., Jaggi, Meena, Chauhan, Subhash C.“…Pancreatic cancer (PanCa) is one of the leading causes of death from cancer in the United States. …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
250por Holyoake, Daniel L.P., Robinson, Maxwell, Grose, Derek, McIntosh, David, Sebag-Montefiore, David, Radhakrishna, Ganesh, Patel, Neel, Partridge, Mike, Mukherjee, Somnath, Hawkins, Maria A.Materias: “…Pancreatic cancer SBRT…”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
251
-
252por Cipora, Elżbieta, Partyka, Olga, Pajewska, Monika, Czerw, Aleksandra, Sygit, Katarzyna, Sygit, Marian, Kaczmarski, Mateusz, Mękal, Dominika, Krzych-Fałta, Edyta, Jurczak, Anna, Karakiewicz-Krawczyk, Katarzyna, Wieder-Huszla, Sylwia, Banaś, Tomasz, Bandurska, Ewa, Ciećko, Weronika, Deptała, Andrzej“…SIMPLE SUMMARY: According to the forecasts, the share of pancreatic cancer in the structure of gastrointestinal malignancies will increase. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
253“…With overall five-year survival rate less than 10%, pancreatic cancer (PC) represents the most lethal one in all human cancers. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
254por Fudalej, Marta, Kwaśniewska, Daria, Nurzyński, Paweł, Badowska-Kozakiewicz, Anna, Mękal, Dominika, Czerw, Aleksandra, Sygit, Katarzyna, Deptała, Andrzej“…SIMPLE SUMMARY: The poor prognosis of pancreatic cancer (PC) is associated with several factors, such as diagnosis at an advanced stage, early distant metastases, and remarkable resistance to most conventional treatment options. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
255por Ijichi, HideakiEnlace del recurso
Publicado 2023
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
256por Bastos, Ana Raquel, Pereira-Marques, Joana, Ferreira, Rui Manuel, Figueiredo, Ceu“…SIMPLE SUMMARY: Pancreatic cancer has one of the worst prognoses among all the malignancies. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
257por Zheng, LeiEnlace del recurso
Publicado 2022
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
258por YANG, HONG, LI, WAN, REN, LIWEN, YANG, YIHUI, ZHANG, YIZHI, GE, BINBIN, LI, SHA, ZHENG, XIANGJIN, LIU, JINYI, ZHANG, SEN, DU, GUANHUA, TANG, BO, WANG, HONGQUAN, WANG, JINHUA“…Pancreatic cancer is a malignant disease characterized by low survival and high recurrence rate, whose patients are mostly at the stage of locally advanced or metastatic disease when first diagnosed. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
259por Olajubutu, Oluwabukunmi, Ogundipe, Omotola D., Adebayo, Amusa, Adesina, Simeon K.“…Pancreatic cancer is fast becoming a global menace and it is projected to be the second leading cause of cancer-related death by 2030. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
260por Keane, Fergus, O’Connor, Catherine A., Park, Wungki, Seufferlein, Thomas, O’Reilly, Eileen M.“…SIMPLE SUMMARY: Pancreatic cancer is associated with poor outcomes for several reasons, including diagnosis at an advanced stage, the absence of effective screening for the diagnosis, and resistance to treatments. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto